PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25065010-0	2015	The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4+ T cell-priming capacity of dendritic cells.	fostamatinib	58-70	CD4 molecule	Homo sapiens	85-88	
25065010-4	2015	METHODS: Antigen-specific in vivo systems and in vitro fluorescence microscopy were combined to investigate the effects of fostamatinib on antigen-specific interactions between dendritic cells (DCs) and CD4(+) T cells.	fostamatinib	123-135	CD4 molecule	Homo sapiens	203-206